A significant wave of patent and data protection expires in 2026 across eight key markets in wave 1: Canada, Brazil, China, India, Mexico , Turkey, Saudi Arabia* and South Africa (see Figure 1)
This uses dissolving microneedle technology, not passive transdermal absorption
Treatment plans are customized by the prescribing provider based on the patients individual needs
Incretin therapies The first generation of weight-loss medications are incretin therapies that regulate insulin secretion, building on type 2 diabetes mellitus (T2DM) treatments utilising glucagon-like peptide-1 (GLP-1) receptor agonists
Ozempic wasnt the first GLP-1 agonist on the market, but its probably the most well-known
it could be about finding the most effective dose for your body's current needs or ensuring you maintain a consistent routine